{
    "Trade/Device Name(s)": [
        "Immunalysis Barbiturates Urine Enzyme Immunoassay",
        "Immunalysis Multi-Drug Calibrators"
    ],
    "Submitter Information": "Immunalysis Corporation",
    "510(k) Number": "K161714",
    "Predicate Device Reference 510(k) Number(s)": [
        "K955928"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DIS",
        "DKB"
    ],
    "Summary Letter Date": "September 1, 2016",
    "Summary Letter Received Date": "September 6, 2016",
    "Submission Date": "October 13, 2016",
    "Regulation Number(s)": [
        "21 CFR 862.3150",
        "21 CFR 862.3200"
    ],
    "Regulation Name(s)": [
        "Barbiturate test system",
        "Calibrators, Drug Specific"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Barbiturates",
        "Secobarbital",
        "Benzoylecgonine",
        "Methamphetamine",
        "Morphine",
        "PCP",
        "Oxazepam"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers",
        "Beckman Coulter AU 400e"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay",
        "Homogeneous enzyme immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Immunalysis Barbiturates Urine Enzyme Immunoassay and Multi-Drug Calibrators for detection and calibration of barbiturates and other drugs in human urine using automated clinical chemistry analyzers.",
    "Indications for Use Summary": "For qualitative and semi-quantitative analysis of barbiturates in human urine with automated clinical chemistry analyzers; calibrators are intended for calibration of immunoassays for specified drugs.",
    "fda_folder": "Toxicology"
}